Aboriginal and Torres Strait Islander people to share the benefits of genomic medicine
Following a granting process in late 2016, an investment of $4.8 million was awarded to Round 1 projects in April 2017.
In Round 1, Queensland Genomics program design was based on:
Round 1 clinical and capability-building projects ran from September 2017 until March 2019.
The objective of the Round 1 clinical projects was to evaluate the use of genomic sequencing to diagnose and manage patients in specific disease areas.
Four disease areas were selected as clinical projects in Round 1:
A core theme of Queensland Genomics’ objectives is to build capability and infrastructure to implement clinical genomics in Queensland healthcare.